Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04699630
Title A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham ACTIVE_NOT_RECRUITING Birmingham Alabama 35249 United States Details
Highlands Oncology Group RECRUITING Springdale Arkansas 72762 United States Details
City of Hope RECRUITING Duarte California 91010 United States Details
Florida Cancer Specialists-South RECRUITING Fort Myers Florida 33901 United States Details
Florida Cancer Specialists-North RECRUITING Saint Petersburg Florida 33705 United States Details
Washington University School of Medicine RECRUITING Saint Louis Missouri 63110 United States Details
Rutgers-Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08903 United States Details
Levine Cancer Institute RECRUITING Charlotte North Carolina 28204 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Tennessee Oncology ACTIVE_NOT_RECRUITING Nashville Tennessee 37203 United States Details
Seattle Cancer Care Alliance RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field